All results

62 results for tests

• United therapeutics 301

  Study ROR-PH-301, ADVANCE OUTCOMES, is designed to assess the efficacy and safety of ralinepag when added to pulmonary arterial hypertension (PAH) standard of…

  Ages

  18 Years - N/A

  Sexes

  All

• Intravesical BCG vs GEMDOCE in NMIBC (BRIDGE)

  The study hypothesis is that BCG naïve non-muscle invasive bladder cancer (NMIBC) patients treated with intravesical Gemcitabine + Docetaxel (GEMDOCE) will…

  Ages

  18 Years - N/A

  Sexes

  All

• ROR-PH-303 (APD811-303)

  Study ROR-PH-303, ADVANCE EXTENSION, is an open-label extension (OLE) study for participants with WHO Group 1 PAH who have participated in another Phase 2 or…

  Ages

  18 Years - N/A

  Sexes

  All

• ARGX-113-2007

  This study's purpose is to measure the treatment response from efgartigimod PH20 SC compared with placebo in participants with Idiopathic Inflammatory Myopathy…

  Ages

  18 Years - N/A

  Sexes

  All

• OCEANIC

  Researchers are looking for a better way to treat people with atrial fibrillation and prevent stroke or systemic embolism (blood clots travelling through the…

  Ages

  18 Years - N/A

  Sexes

  All

• HEALEY ALS Platform Trial

  The HEALEY ALS Platform Trial is a perpetual multi-center, multi-regimen clinical trial evaluating the safety and efficacy of investigational products for the…

  Ages

  18 Years - N/A

  Sexes

  All

• Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease (CIRCULATE-US)

  This Phase II/III trial will evaluate the what kind of chemotherapy to recommend to patients based on the presence or absences of circulating tumor DNA (ctDNA)…

  Ages

  18 Years - N/A

  Sexes

  All

• INfluenza Vaccine to Effectively Stop Cardio Thoracic Events and Decompensated Heart Failure

  INVESTED will test the hypothesis that high dose trivalent influenza vaccine will reduce cardiopulmonary events to a greater extent than standard dose…

  Ages

  18 Years - N/A

  Sexes

  All

• RECOVER VITAL

  This study is a platform protocol designed to be flexible so that it is suitable for a wide range of settings within health care systems and in community…

  Ages

  18 Years - N/A

  Sexes

  All

• Enroll-HD: A Prospective Registry Study in a Global Huntington's Disease Cohort

  Enroll-HD is a longitudinal, observational, multinational study that integrates two former Huntington's disease (HD) registries-REGISTRY in Europe, and COHORT…

  Ages

  18 Years - N/A

  Sexes

  All